Presentations at Association for Molecular Pathology 2025 Annual Meeting Spotlight Clinical Impact of Delve Bio’s Metagenomic Sequencing Test for Improving CNS Diagnosis Delve Detect delivers 22 ...

Robot-Assisted PCI as a Strategy to Reduce the Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses Receive the the latest news, research, and presentations from major ...

Delve Detect delivers 22 percent greater diagnostic yield with results the next day, offering an important new tool for managing complex central nervous system infections, including co-infection and ...

CARLSBAD, Calif., November 13, 2025--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection ...

Case Presentation Conclusion: How and Why Did We Treat? What Were the Outcomes? Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by ...

Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital ...

The goal of the CBTP is to train PhD and MD/PhD scientists who will advance research on the causes, diagnosis, progression and treatment of experimental and human cancer. The CBTP provides a PhD ...